Transfusion Reactions

  • Janice P. Dutcher

Abstract

Transfusion supportive care is an important adjunct to the successful management of patients with malignancy, both those with hematologic malignancies and those with solid tumors. Transfusion supportive care in hematology/oncology involves the use of a variety of blood products, the majority being red blood cells and platelets, but on occasion granulocytes, fresh frozen plasma, and plasma components.

Keywords

Human Leukocyte Antigen Blood Product Disseminate Intravascular Coagulation Transfusion Reaction Granulocyte Transfusion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Holland PV: Other adverse effects of transfusion, in Petz L, Swisher S (eds); Clinical Practice of Blood Transfusion. AR Liss, New York, 1984, pp 783–803.Google Scholar
  2. 2.
    Mollison PL: Blood Transfusion in Clinical Medicine, 7th ed. Oxford, Blackwell, 1983.Google Scholar
  3. 3.
    Kickler TS: Managing the acute adverse effects of transfusion therapy. J Crit Illness May(5): 26–39, 1986.Google Scholar
  4. 4.
    Snyder EL, Root RK, Hezzy A, Metcalf J, Palermo G: Effect of microaggregate blood filtration on granulocyte concentrated in vitro. Transfusion 23: 25–29, 1983.PubMedCrossRefGoogle Scholar
  5. 5.
    Wenz B: Microaggregate blood filtration and the febrile transfusion reaction. Transfusion 23: 95–98, 1983.PubMedCrossRefGoogle Scholar
  6. 6.
    Meryman HT, Hornblower M: The preparation of red cells depleted of leukocytes. Transfusion 26: 101–106, 1986.PubMedCrossRefGoogle Scholar
  7. 7.
    Popovsky MA, Moore SB: Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 25: 573–577, 1985.PubMedCrossRefGoogle Scholar
  8. 8.
    Schmidt PJ: Clinical-pathological concepts of hemolytic transfusion reactions, in Sandler SG, Jamieson GA (eds): Immunobiology of the Erythrocyte New York, AR Liss, 1980.Google Scholar
  9. 9.
    Goldfinger D: Acute hemolytic transfusion reactions—a fresh look at pathogenesis and considerations regarding therapy. Transfusion 17: 85–90, 1975.CrossRefGoogle Scholar
  10. 10.
    Morrison FS, Mollison PL: Post-transfusion purpura. N Engl J Med 275: 243–248, 1966.PubMedCrossRefGoogle Scholar
  11. 11.
    Vogelsang G, Kickler TS, Bell WR: Post-transfusion purpura: A report of five patients and a review of the pathogenesis and management. Am J Hematol 21: 259–267, 1986.PubMedCrossRefGoogle Scholar
  12. 12.
    Vyas GN, Holmdahl L, Perkins HA, Fudenbert HH: Serologic specificity of human anti-IgA and its significance in transfusion. Blood 34: 573–578, 1969.PubMedGoogle Scholar
  13. 13.
    Alving B, Hojima Y, Pisano JJ, Mason BL, Buckingham RE, Mozen MM, Finlayson JS: Hypotension associated with pre-kallikrein activator in plasma protein fraction. N Engl J Med 299: 66–71, 1978.PubMedCrossRefGoogle Scholar
  14. 14.
    Dutcher JP, Schiffer CA, Aisner J, Wiernik PH: Alloimmunization following platelet transfusion: The absence of a dose-response relationship. Blood 57: 395–398, 1981.PubMedGoogle Scholar
  15. 15.
    Halohan TV, Terasaki PH, Deisseroth AB: Suppression of transfusion related alloimmunization in intensively treated cancer patients. Blood 58: 122–127, 1981.Google Scholar
  16. 16.
    Heal JM, Singal S, Sardisco E, Mayer T: Bacterial proliferation in platelet concentrates. Transfusion 26: 388–390, 1986.PubMedCrossRefGoogle Scholar
  17. 17.
    Braine HG, Kickler TS, Charache P, Ness PM, David J, Reichart C, Fuller AK: Bacterial sepsis secondary to platelet transfusion: An adverse effect of extended storage at room temperature. Transfusion 26: 391–393, 1986.PubMedCrossRefGoogle Scholar
  18. 18.
    Dutcher JP: Granulocyte transfusion therapy. Am J Med Sci 287: 13–19, 1984.CrossRefGoogle Scholar
  19. 19.
    Karp DD, Ervin TJ, Tuttle S: Pulmonary complications during granulocyte transfusions: Incidence and clinical features. Vox Sang 42: 57–59, 1982.PubMedCrossRefGoogle Scholar
  20. 20.
    Higby DJ, Mishler JM, Cohen E, Rhombert W, Nicora RW, Holland JF: Increased elevation of peripheral leukocyte counts by infusion of histocompatible granulocytes. Vox Sang 27: 180189, 1974.Google Scholar
  21. 21.
    Dutcher JP, Schiffer CA, Johnson GS, Papenberg D, Daly PA, Aisner J, Wiernik PH: Alloimmunization prevents the migration of transfused indium-111-labeled granulocytes to sites of infection. Blood 62: 354–360, 1983.PubMedGoogle Scholar
  22. 22.
    Wright DG, Robichand KJ, Pizzo PA, Deisseroth AB: Lethal pulmonary reactions associated with the combined use of amphotericin B and leukocyte transfusions. N Engl J Med 304: 1185 1189, 1981.Google Scholar
  23. 23.
    Dana BW, Durie BGM, White RF, Huestis DW: Concomitant administration of granulocyte transfusions and amphotericin-B in neutropenic patients: Absence of significant pulmonary toxicity. Blood 57: 90–94, 1982.Google Scholar
  24. 24.
    Dutcher JP, Kendall J, Papenberg D, Schiffer CA, Aisner J, Wiernik PH: Concurrent administration of amphotericin B (Ampho) and granulocyte transfusions (Gran Tx): Lack of a detrimental effect. Clin Res 34: 561A, 1986.Google Scholar
  25. 25.
    Boxer LA, Ingraham LM, Allen R, Oseas RS, Baehner RL: Amphotericin B promotes leukocyte aggregation of nylon-wool, fiber-treated polymorphonuclear leukocytes. Blood 58: 518522, 1981.Google Scholar
  26. 26.
    Winston DJ, Ho WG, Howell CL, Miller MJ, Mickey R, Martin WJ, Lin CH, Gale RP: Cytomegalovirus infections associated with leukocyte tranfusions. Ann Intern Med 93: 671, 1980.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1987

Authors and Affiliations

  • Janice P. Dutcher
    • 1
  1. 1.Department of Medicine, Division of Medical Oncology, Albert Einstein College of Medicine, and Department of OncologyMontefiore Medical CenterBronxUSA

Personalised recommendations